Preoperative mediastinal and hilar nodal staging with diffusion-weighted magnetic resonance imaging and fluorodeoxyglucose positron emission tomography/computed tomography in patients with non-small-cell lung cancer: Which is better?

Journal of Surgical Research

Volumn 178, Issue 1, 2012, Pages 304-314

  Wu, Lian Ming ^a   Xu, Jian Rong ^a   Gu, Hai Yan ^a   Hua, Jia ^a   Chen, Jie ^a   Zhang, Wei ^a   Haacke, E Mark ^b   Hu, Jiani ^b  

^a SHANGHAI JIAO TONG UNIVERSITY SCHOOL OF MEDICINE   (China)

^b WAYNE STATE UNIVERSITY   (United States)

Author keywords

18F fluorodeoxyglucose positron emission tomography computed tomography; 18F FDG PET CT; Diffusion weighted magnetic resonance imaging; Mediastinal and hilar lymph node staging; Non small cell lung cancer

Indexed keywords

FLUORODEOXYGLUCOSE;

ADULT; AGED; ARTICLE; CANCER PATIENT; CANCER STAGING; COMPARATIVE STUDY; COMPUTER ASSISTED EMISSION TOMOGRAPHY; CONFIDENCE INTERVAL; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; DIFFUSION WEIGHTED IMAGING; HUMAN; LUNG NON SMALL CELL CANCER; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MEDIASTINUM LYMPH NODE; META ANALYSIS; NON INVASIVE PROCEDURE; PRIORITY JOURNAL; RECEIVER OPERATING CHARACTERISTIC; SENSITIVITY AND SPECIFICITY;

ADOLESCENT; ADULT; AGED; AGED, 80 AND OVER; CARCINOMA, NON-SMALL-CELL LUNG; DIFFUSION MAGNETIC RESONANCE IMAGING; FEMALE; FLUORODEOXYGLUCOSE F18; HUMANS; LUNG NEOPLASMS; MALE; MIDDLE AGED; NEOPLASM STAGING; POSITRON-EMISSION TOMOGRAPHY AND COMPUTED TOMOGRAPHY; PREOPERATIVE CARE; RADIOPHARMACEUTICALS; YOUNG ADULT;

EID: 84868196074     PISSN: 00224804     EISSN: 10958673     Source Type: Journal    
DOI: 10.1016/j.jss.2012.03.074     Document Type: Article

References (67)

1. A. Jemal, K.C. Chu, and R.E. Tarone Recent trends in lung cancer mortality in the United States J Natl Cancer Inst 93 2001 277
2. C.M. Free, M. Ellis, and L. Beggs Lung cancer outcomes at a UK cancer unit between 1998-2001 Lung Cancer 57 2007 222
3. M. Okada, K. Yoshikawa, and T. Hatta Is segmentectomy with lymph node assessment an alternative to lobectomy for nonsmall cell lung cancer of 2 cm or smaller? Ann Thorac Surg 71 2001 956
4. H. Onishi, T. Araki, and H. Shirato Stereotactic hypofractionated high-dose irradiation for stage I nonsmall cell lung carcinoma: Clinical outcomes in 245 subjects in a Japanese multiinstitutional study Cancer 101 2004 1623
5. K. Nakamura, H. Saji, and R. Nakajima A phase III randomized trial of lobectomy versus limited resection for small-sized peripheral non-small cell lung cancer (JCOG0802/WJOG4607L) Jpn J Clin Oncol 40 2010 271
6. G.M. Glazer, M.B. Orringer, and B.H. Gross The mediastinum in non-small cell lung cancer: CT-surgical correlation AJR Am J Roentgenol 142 1984 1101
7. G.M. Glazer, B.H. Gross, and A.M. Aisen Imaging of the pulmonary hilum: A prospective comparative study in patients with lung cancer AJR Am J Roentgenol 145 1985 245
8. N. Martini, R. Heelan, and J. Westcott Comparative merits of conventional, computed tomographic, and magnetic resonance imaging in assessing mediastinal involvement in surgically confirmed lung carcinoma J Thorac Cardiovasc Surg 90 1985 639
9. D. Musset, P. Grenier, and M.F. Carette Primary lung cancer staging: Prospective comparative study of MR imaging with CT Radiology 160 1986 607
10. F. Laurent, J. Drouillard, and F. Dorcier Bronchogenic carcinoma staging: CT versus MR imaging-assessment with surgery Eur J Cardiothorac Surg 2 1988 31
11. K.B. Nolop, C.G. Rhodes, and L.H. Brudin Glucose utilization in vivo by human pulmonary neoplasms Cancer 60 1987 2682
12. H. Van Tinteren, O.S. Hoekstra, and E.F. Smit Effectiveness of positron emission tomography in the preoperative assessment of patients with suspected non small cell lung cancer: The PLUS multicentre randomized trial Lancet 359 2002 1388
13. R.C. Viney, M.J. Boyer, and M.T. King Randomized controlled trial of the role of positron emission tomography in the management of stage I and II non small cell lung cancer J Clin Oncol 22 2004 2357
14. 18F]fluorodeoxyglucose-positron emission tomography staging of non small cell lung cancer: A Dutch cooperative randomized study J Clin Oncol 24 2006 1800
15. B. Fischer, U. Lassen, and J. Mortensen Preoperative staging of lung cancer with combined PET-CT N Eng J Med 361 2009 32
16. D.E. Maziak, G.E. Darling, and R.I. Inculet Positron emission tomography in staging early lung cancer: A randomized trial Ann Intern Med 151 2009 221
17. D. Lardinois, W. Weder, and T.F. Hany Staging of non-small-cell lung cancer with integrated positron-emission-tomography and computed tomography N Engl J Med 348 2003 2500
18. H. Nomori, T. Mori, and K. Ikeda Diffusion weighted magnetic resonance imaging can be used in place of positron emission tomography for N staging of non-small cell lung cancer with fewer false-positive results J Thorac Cardiovasc Surg 135 2008 816
19. W. Chen, W. Jian, and H.T. Li Whole-body diffusion-weighted imaging vs. FDG-PET for the detection of non-small-cell lung cancer: How do they measure up? Magn Reson Imaging 28 2010 613
20. D.M. Koh, and D.J. Collins Diffusion-weighted MRI in the body: Applications and challenges in oncology AJR Am J Roentgenol 188 2007 1622
21. P. Whiting, A.W. Rutjes, and J.B. Reitsma The development of QUADAS: A tool for the quality assessment of studies of diagnostic accuracy included in systematic reviews BMC Med Res Methodol 3 2003 25
22. C.M. Rutter, and C.A. Gatsonis A hierarchical regression approach to metaanalysis of diagnostic test accuracy evaluations Stat Med 20 2001 2865
23. Y. Ohno, H. Koyama, and Y. Onishi Non-small cell lung cancer: Whole-body MR examination for M-stage assessment - Utility for whole-body diffusion-weighted imaging compared with integrated FDG PET/CT Radiology 248 2008 643
24. P. Koşucu, C. Tekinbaş, and M. Erol Mediastinal lymph nodes: Assessment with diffusion-weighted MR imaging J Magn Reson Imaging 30 2009 292
25. T. Shinya, K. Rai, and Y. Okumura Dual-timepoint F-18FDG PET/CT for evaluation of intrathoracic lymph nodes in patients with non-small cell lung cancer Clin Nucl Med 34 2009 216
26. X. Zhang, T.R. Li, and Z.S. Chen Comparing serum tumor antigen detection combined with CT scan with PET-CT for lung cancer diagnosis Ai Zheng 25 2006 66
27. 18F-FDG PET-CT in defining lymph node radiation target volume for non-small-cell lung cancer patients Zhonghua Zhong Liu Za Zhi 29 2007 453
28. A.S. Bryant, and R.J. Cerfolio The clinical stage of non-small cell lung cancer as assessed by means of fluorodeoxyglucose-positron emission tomographic/computed tomographic scanning is less accurate in cigarette smokers J Thorac Cardiovasc Surg 132 2006 1363
29. N. Al-Sarraf, R. Aziz, and K. Doddakula Factors causing inaccurate staging of mediastinal nodal involvement in non-small cell lung cancer patients staged by positron emission tomography Interact Cardiovasc Thorac Surg 6 2007 350
30. L.H. Hsu, J.S. Ko, and D.L. You Transbronchial needle aspiration accurately diagnoses subcentimetre mediastinal and hilar lymph nodes detected by integrated positron emission tomography and computed tomography Respirology 12 2007 848
31. N. Al-Sarraf, R. Aziz, and K. Gately Pattern and predictors of occult mediastinal lymph node involvement in non-small cell lung cancer patients with negative mediastinal uptake on positron emission tomography Eur J Cardiothorac Surg 33 2008 104
32. A. Gomez-Caro, S. Garcia, and N. Reguart Incidence of occult mediastinal node involvement in cN0 non-small-cell lung cancer patients after negative uptake of positron emission tomography/computed tomography scan Eur J Cardiothorac Surg 37 2010 1168
33. H.J. Lee, Y.T. Kim, and W.J. Kang Integrated positron emission tomography for nodal staging in lung cancer Asian Cardiovasc Thorac Ann 17 2009 622
34. B.J. Liu, J.C. Dong, and C.Q. Xu Accuracy of 18F-FDG PET/CT for lymph node staging in non-small-cell lung cancers Chin Med J 122 2009 1749
35. R. Kanzaki, M. Higashiyama, and A. Fujiwara Occult mediastinal lymph node metastasis in NSCLC patients diagnosed as clinical N0-1 by preoperative integrated FDG-PET/CT and CT: Risk factors, pattern, and histopathological study Lung Cancer 71 2011 333
36. G. Autoch, J. Stattaus, and A.T. Nemat Non-small cell lung cancer: Dual-modality PET-CT in preoperative staging Radiology 229 2003 526
37. 18F-FDG PET/CT with double quantitative SUVmax and CT value Chin J Clin Oncol 38 2011 284
38. H. Toba, K. Kondo, and H. Otsuka Diagnosis of the presence of lymph node metastasis and decision of operative indication using fluorodeoxyglucose- positron emission tomography and computed tomography in patients with primary lung cancer J Med Invest 57 2010 305
39. M. Morikawa, Y. Demura, and T. Ishizaki The effectiveness of 18F-FDG PET/CT combined with STIR MRI for diagnosing nodal involvement in the thorax J Nucl Med 50 2009 81
40. K. Usuda, X.T. Zhao, and M. Sagawa Diffusion-weighted imaging is superior to positron emission tomography in the detection and nodal assessment of lung cancers Ann Thorac Surg 91 2011 1689
41. R. Sánchez Sánchez, A. Rodríguez Fernández, and M. Gómez Río Utility of PET/CT for mediastinal staging of non-small cell lung cancer in stage III (N2) Rev Esp Med Nucl 30 2011 211
42. I. Iskender, S.Z. Kadioglu, and A. Kosar Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography/computerised tomography in patients with non-small-cell lung cancer Interact Cardio Vasc Thorac Surg 12 2011 965
43. B.M. Fischer, J. Mortensen, and H. Hansen Multimodality approach to mediastinal staging in non-small cell lung cancer: Faults and benefits of PET-CT: A randomised trial Thorax 66 2011 294
44. C. Perigaud, B. Bridji, and J.C. Roussel Prospective preoperative mediastinal lymph node staging by integrated positron emission tomography-computerised tomography in patients with non-small-cell lung cancer Eur J Cardiothorac Surg 36 2009 731
45. B. Hwangbo, S.K. Kim, and H.S. Lee Application of endobronchial ultrasound-guided transbronchial needle aspiration following integrated PET/CT in mediastinal staging of potentially operable non-small cell lung cancer Chest 135 2009 1280
46. Y. Ohno, H. Koyama, and T. Yoshikawa N stage disease in patients with non-small cell lung cancer: Efficacy of quantitative and qualitative assessment with STIR turbo spin-echo imaging, diffusion-weighted MR imaging, and fluorodeoxyglucose PET/CT Radiology 261 2011 605
47. Li M, Wu N, Liu Y, et al. Regional nodal staging with (18)F-FDG PET-CT in non-small cell lung cancer: Additional diagnostic value of CT attenuation and dual-time-point imaging. Eur J Radiol Epub 2011 Apr 19.
48. Li X, Zhang H, Xing L, et al. Mediastinal lymph nodes staging by (18)F-FDG PET/CT for early stage non-small cell lung cancer: A multicenter study. Radiother Oncol Epub 2011 Nov 17.
49. K. Kubota, K. Murakami, and T. Inoue Additional value of FDG-PET to contrast enhanced-computed tomography (CT) for the diagnosis of mediastinal lymph node metastasis in non-small cell lung cancer: A Japanese multicenter clinical study Ann Nucl Med 25 2011 777
50. M. Hu, A. Han, and L. Xing Value of dual-time-point FDG PET/CT for mediastinal nodal staging in non-small-cell lung cancer patients with lung comorbidity Clin Nucl Med 36 2011 429
51. G.E. Darling, D.E. Maziak, and R.I. Inculet Positron emission tomography-computed tomography compared with invasive mediastinal staging in non-small cell lung cancer: Results of mediastinal staging in the early lung positron emission tomography trial J Thorac Oncol 6 2011 1367
52. J. Nakayama, K. Miyasaka, and T. Omatsu Metastases in mediastinal and hilar lymph nodes in patients with non-small cell lung cancer: Quantitative assessment with diffusion-weighted magnetic resonance imaging and apparent diffusion coefficient J Comput Assist Tomogr 34 2010 1
53. E. Tasci, C. Tezel, and A. Orki The role of integrated positron emission tomography and computed tomography in the assessment of nodal spread in cases with non-small cell lung cancer Interact Cardiovasc Thorac Surg 10 2010 200
54. X.D. Li, J.L. Yin, and W.K. Liu Value of positron emission tomography-computed tomography in the diagnosis of mediastinal lymph node metastasis of non-small cell lung cancer Nan Fang Yi Ke Da Xue Xue Bao 30 2010 506
55. T.Y. Jeon, K.S. Lee, and C.A. Yi Incremental value of PET/CT over CT for mediastinal nodal staging of non-small cell lung cancer: Comparison between patients with and without idiopathic pulmonary fibrosis AJR Am J Roentgenol 195 2010 370
56. M. Sanli, A.F. Isik, and S. Zincirkeser Reliability of positron emission tomography-computed tomography in identification of mediastinal lymph node status in patients with non-small cell lung cancer J Thorac Cardiovasc Surg 138 2009 1200
57. 18F-FDG PET/CT in mediastinal lymph node staging of non-small-cell lung cancer in a tuberculosis-endemic country: Consideration of lymph node calcification and distribution pattern to improve specificity Eur J Nucl Med Mol Imaging 36 2009 1794
58. A. Billé, E. Pelosi, and A. Skanjeti Preoperative intrathoracic lymph node staging in patients with non-small-cell lung cancer: Accuracy of integrated positron emission tomography and computed tomography Eur J Cardiothorac Surg 36 2009 440
59. I. Hasegawa, P.M. Boiselle, and K. Kuwabara Mediastinal lymph nodes in patients with non-small cell lung cancer: Preliminary experience with diffusion-weighted MR imaging J Thorac Imaging 23 2008 157
60. W.F. Yang, Z. Fu, and J.M. Yu Value of PET/CT versus enhanced CT for locoregional lymph nodes in non-small cell lung cancer Lung Cancer 61 2008 35
61. C. Plathow, P. Aschoff, and M.P. Lichy Positron emission tomography/computed tomography and whole-body magnetic resonance imaging in staging of advanced non-small cell lung cancer: Initial results Invest Radiol 43 2008 290
62. B.E. Lee, D. von Haag, and T. Lown Advances in positron emission tomography technology have increased the need for surgical staging in non-small cell lung cancer J Thorac Cardiovasc Surg 133 2007 746
63. Y.K. Kim, K.S. Lee, and B.T. Kim Mediastinal nodal staging of nonsmall cell lung cancer using integrated 18F-FDG PET/CT in a tuberculosis endemic country: Diagnostic efficacy in 674 patients Cancer 109 2007 1068
64. B.S. Halpern, C. Schiepers, and W.A. Weber Presurgical staging of non-small cell lung cancer: Positron emission tomography, integrated positron emission tomography/CT, and software image fusion Chest 128 2005 2289
65. P.F. Roberts, D.M. Follette, and D. Haag Factors associated with false positive staging of lung cancer by positron emission tomography Ann Thorac Surg 70 2000 1154
66. P. Kosucu, C. Tekinbas, and M. Erol Mediastinal lymph nodes: Assessment with diffusion-weighted MR imaging J Magn Reson Imaging 30 2009 292
67. R. Jaeschke, G.H. Guyatt, and D.L. Sackett Users' guides to the medical literature. III. How to use an article about a diagnostic test. B. What are the results and will they help me in caring for my patients? The Evidence-Based Medicine Working Group JAMA 271 1994 703